Xiangrong Song
Seminars
Thursday 2nd January 2025
Updates & Interim Data of mRNA-Based Cancer Vaccines to Treat EBV-Related Cancers
1:45 pm
- Presenting the latest clinical data for breakthroughs in the treatment of EBV-related cancers, including NPC and NKT lymphoma
- Highlighting safety and efficacy based on ongoing enrolment and interim data from clinical trials
- Demonstrating the transformative potential of mRNA therapeutics in the treatment of viralrelated malignancies
